Investigation of the anticancer effect of newly synthesized palladium conjugate Schiff base metal complexes on non-small cell lung cancer cell line and mouse embryonic fibroblast cell line
Biochemical and Biophysical Research Communications · 2024-11 · 735 · 150658
DOI: 10.1016/j.bbrc.2024.150658 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024-11. Verfasst von Burcu Demirbağ und 6 weiteren Autor:innen. Beteiligte Einrichtung: Mersin University, Faculty of Medicine, Department of Stem Cell and Regenerative Medical, Mersin, Turkey. Hauptthemen laut MEDLINE: Antineoplastic Agents, Carcinoma, Non-Small-Cell Lung, Coordination Complexes, Palladium. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Eskişehir Technical University, Mersin University.
Abstract (Originalsprache)
Lung cancer remains one of the leading causes of death worldwide. Due to the side effects of chemotherapeutic agents on normal cells and the development of resistance by cancer cells, there is an urgent need for alternative new pharmacological agents. Palladium (Pd)-conjugated Schiff base (SB) compounds represent an alternative approach with promising potential applications in cancer treatment. This study aims to identify novel therapeutic agents on A549 cells through the synthesis and characterization of Schiff base conjugated-Palladium complexes (Pd-L1 and Pd-L2). Additionally, it seeks to elucidate the mechanism of action of these compounds on both the A549 and NIH/3T3 cell lines. In the present study, two new Pd-L1 and Pd-L2 were synthesized for the first time and characterized mainly by single crystal X-ray diffraction and 1H, 13C, 31P NMR techniques. The cytotoxic effect of the compounds was evaluated by MTT assay on A549 and NIH/3T3 cell lines for 24 and 48 h. Cisplatin was used as a positive control group. Based on the cytotoxicity results, the complexes were evaluated for their anticancer activities against A549 cell lines for 48 h through reactive oxygen species (ROS), cell cycle, apoptotic, and necrotic cell analyses. The most potent cytotoxic effects were determined for Pd-L1 (IC50: 23.33 μM), Pd-L2 (IC50: 3.19 μM), and cisplatin (IC50: 33.27 μM) on A549 cells (p < 0.05). The compounds exhibited a significant cytotoxic effect at lower concentrations on A549 cells compared to NIH/3T3 cells (p < 0.05). All compounds showed a significant increase in ROS levels in A549 cells compared to the control group (p < 0.05). While necrosis and apoptosis was observed in A549 cells treated with cisplatin, induction of apoptosis was effective in cell death for A549 cells treated with Pd-L1 and Pd-L2 (p < 0.05). Additionally, it was observed that the compounds inhibited cell proliferation in the G0/G1 and G2/M cell cycle phases (p < 0.05). All compounds induced cell cycle arrest and cell death in A549 cells by increasing ROS levels. The results obtained in the present study could advance the utilization of the compounds as anticancer agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Mersin University, Faculty of Medicine, Department of Stem Cell and Regenerative Medical, Mersin, Turkey.
- Mersin University, Faculty of Medicine, Department of Stem Cell and Regenerative Medical, Mersin, Turkey; Mersin University, Faculty of Medicine, Department of Medical Pharmacology, Mersin, Turkey.
- Mersin University, Faculty of Medicine, Department of Medical Microbiology, Mersin, Turkey.
- Harran University, Faculty of Pharmacy, Department of Biochemistry, Şanlıurfa, Turkey. Electronic address: metinyildirim4@gmail.com.
- Mersin University, Faculty of Medicine, Department of Medical Biology and Genetics, Mersin, Turkey.
- Eskisehir Technical University, Faculty of Science, Department of Chemistry, Eskisehir, Turkey.
Förderung
- Eskişehir Technical University
- Mersin University
Zitieren
APA
Demirbağ, B., Büyükafşar, K., Kaya, H., Yıldırım, M., Bucak, Ö., Ünver, H., & Erdoğan, S. (2024). Investigation of the anticancer effect of newly synthesized palladium conjugate Schiff base metal complexes on non-small cell lung cancer cell line and mouse embryonic fibroblast cell line. Biochemical and Biophysical Research Communications, 735, 150658. https://doi.org/10.1016/j.bbrc.2024.150658
Vancouver
Demirbağ B, Büyükafşar K, Kaya H, Yıldırım M, Bucak Ö, Ünver H, et al. Investigation of the anticancer effect of newly synthesized palladium conjugate Schiff base metal complexes on non-small cell lung cancer cell line and mouse embryonic fibroblast cell line. Biochemical and Biophysical Research Communications. 2024;735:150658. doi:10.1016/j.bbrc.2024.150658
BibTeX
@article{Demirba2024,
author = {Demirbağ, Burcu and Büyükafşar, Kansu and Kaya, Hamide and Yıldırım, Metin and Bucak, Öznur and Ünver, Hakan and Erdoğan, Semra},
title = {Investigation of the anticancer effect of newly synthesized palladium conjugate Schiff base metal complexes on non-small cell lung cancer cell line and mouse embryonic fibroblast cell line},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
volume = {735},
pages = {150658},
doi = {10.1016/j.bbrc.2024.150658}
}
EUVIMED